Latest News in the pharma Industry

Biopharma News

Sartorius Stedim Biotech launches innovative ambr 250 modular bioreactor system

Sartorius Stedim Biotech launches innovative ambr 250 modular bioreactor system

15 Jun 2016

New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture.

Read more 
New Sartorius Stedim BioOutsource microsite goes live

New Sartorius Stedim BioOutsource microsite goes live

14 Jun 2016

Cellca’s cell line and upstream process development services now integrated.

Read more 
Health Canada approves Inflectra (biosimilar infliximab) for three additional indications

Health Canada approves Inflectra (biosimilar infliximab) for three additional indications

14 Jun 2016

The addition of Crohn's disease, fistulising Crohn's disease and ulcerative colitis to the approved indications was granted on the basis of similarity between Inflectra and the reference product, Remicade.

Read more 
Sartorius Stedim Biotech presents Virosart Media

Sartorius Stedim Biotech presents Virosart Media

13 Jun 2016

Offers a fast and cost-effective solution for manufacturers to reduce the risk of virus contamination resulting from raw materials during fermentation.

Read more 
Merck expands its Investment Fund Merck Ventures

Merck expands its Investment Fund Merck Ventures

8 Jun 2016

Total fund size doubled to up to €300 million.

Read more 
Alvotech opens state-of-the-art biosimilar facility in Iceland

Alvotech opens state-of-the-art biosimilar facility in Iceland

8 Jun 2016

The new facility will significantly increase Alvotech’s production capacity enabling the group to produce higher yields at lower costs.

Read more 
SGS introduces new hydrogen deuterium exchange capabilities for protein characterisation and biopharmaceutical development

SGS introduces new hydrogen deuterium exchange capabilities for protein characterisation and biopharmaceutical development

6 Jun 2016

Company will be one of the first service providers to offer HDX-MS in a cGMP environment.

Read more 
Fujifilm Diosynth collaborates with MSD on a new 20,000-L microbial biologics facility

Fujifilm Diosynth collaborates with MSD on a new 20,000-L microbial biologics facility

6 Jun 2016

Enables Fujifilm Diosynth’s customers to benefit from MSD’s strong track record with large-scale microbial operations.

Read more 
CMC Biologics expands GMP manufacturing capacity in Europe

CMC Biologics expands GMP manufacturing capacity in Europe

2 Jun 2016

Addition of a Bioreactor 3PACK production facility to its Copenhagen facility provides additional flexible solutions for clients.

Read more 
WuXi Biologics and Sartorius Stedim Biotech open joint laboratory in Shanghai

WuXi Biologics and Sartorius Stedim Biotech open joint laboratory in Shanghai

1 Jun 2016

Certified leading upstream platform powers China’s biopharmaceutical development.

Read more 
Flixabi, Biogen’s infliximab biosimilar referencing Remicade, approved in the EU

Flixabi, Biogen’s infliximab biosimilar referencing Remicade, approved in the EU

30 May 2016

Biogen to manufacture and commercialize Flixabi, the company’s second anti-TNF biosimilar therapy in the EU.

Read more 
BioPharma Services USA awarded a 5 Year, $20 million contract with the FDA

BioPharma Services USA awarded a 5 Year, $20 million contract with the FDA

22 May 2016

The contract is to conduct in vivo studies of generic drug products in human subjects from 2016 through to 2021.

Read more